Dr. Chi on the TITAN Trial Results in Metastatic Castration-Sensitive Prostate Cancer Published 2019-06-01 Download video MP4 360p Recommendations 22:01 Chemotherapy In #ProstateCancer | The PSA Response & Side Effects | #MarkScholzMD #AlexScholz 04:23 Apalutamide for High-Risk Prostate Cancer | Learn About Clinical Trials 11:40 How Cleaning Can Change Your Life 03:28 Apalutamide and the TITAN Clinical Trial 00:47 Systemic triple therapy in metastatic hormone-sensitive prostate cancer 01:15 Dr. Agarwal on Impact of the TITAN Trial With Apalutamide Plus ADT in mCSPC 02:58 Patients reportedly beating cancer with just one tablet a day | 9 News Australia 06:49 How do You Treat Oligometastatic Prostate Cancer and What Does Cure Mean? | Ask a Prostate Expert 03:44 The evolving standard of care for patients with metastatic hormone-sensitive prostate cancer 02:52 Chemotherapy for Prostate Cancer | Professor Anthony Joshua 08:33 TITAN Phase 3 Trial with Apalutamide in Metastatic Castration Sensitive Prostate Cancer 02:50 Live from ASCO: Apalutamide for Castration-Sensitive Prostate Cancer 02:29 Update: FDA Approves Apalutamide (Erleada) for Metastatic Castration-Sensitive Prostate Cancer 01:56 ARASENS: dialuramide plus ADT and docetaxel for metastatic hormone-sensitive prostate cancer 02:05 STARTAR: ADT with apalutamide, radiation therapy and docetaxel in prostate cancer 13:15 Titan Trial 19:59 Шоумен посипався. Захід побачив істинне лице Зеленського // Без цензури // Цензор.НЕТ 43:49 Știrile PRO TV - 2 Februarie 2024 01:03 Dr. Yu on the Drawbacks of Radiation Therapy in Prostate Cancer Similar videos 13:05 TITAN: update on the data and where next for patients with hormone sensitive PC 00:54 Kim Chi, MD, regarding the TITAN study presented at ASCO 2019 00:54 Apalutamide Combination is Well Tolerated in Metastatic Castration-Sensitive Prostate Cancer 01:38 Kim N. Chi, MD, regarding key highlights from the final analysis of the Phase III TITAN study 02:05 Abiraterone in metastatic castration-sensitive prostate cancer 01:28 Apalutamide Plus ADT Leads to Survival Benefit in mCSPC 07:08 Expert video report on Prostate Cancer from 2021 Genitourinary Cancers Symposium 02:28 Dr. Yu on Treatment Intensification in Metastatic Castration-Sensitive Prostate Cancer 05:48 Data for Metastatic Castration-Sensitive Prostate Cancer 09:01 Prostate cancer updates: TITAN and ENZAMET 25:31 Management of Advanced Hormone-sensitive and Castration-resistant Prostate Cancer 04:24 EMUC18: STAMPEDE trial 02:58 Expert comment: ENZAMET and TITAN trials | Earle Burgess 00:57 Dr. Chi on the Rationale for the PC-BETS Study With ctDNA in Prostate Cancer More results